Assignee
ADAGENE PTE LTD
SG·0 granted patents·9 pending applications·0 citations·filing 2020–2023
Top patents by PatentIndex Score
9 records- 0161US2025257133A1Anti-CD28 Antibodies and Methods of Use ThereofADAGENE PTE LTD·Filed 2023·Application pending·0 cites
- 0261US2025188179A1Anti-cd137 antibodies and methods of making and using the sameADAGENE PTE LTD·Filed 2023·Application pending·0 cites
- 0359US2025326847A1Activatable anti-ctla4 antibodies for treating cancerADAGENE PTE LTD·Filed 2023·Application pending·0 cites
- 0459US2026085119A1Methods for treating cancer using anti-ctla4 antibodiesADAGENE PTE LTD·Filed 2023·Application pending·0 cites
- 0557US2024417463A1Anti-cd47 antibodies and methods of use thereofADAGENE PTE LTD·Filed 2022·Application pending·0 cites
- 0656US2025326860A1Anti-cd3 antibodies and methods of use thereofADAGENE PTE LTD·Filed 2022·Application pending·0 cites
- 0754US2024209091A1Methods for treating cancer using anti-ctla4 antibodiesADAGENE PTE LTD·Filed 2022·Application pending·0 cites
- 0852US2023242663A1Combination therapy comprising anti-cd137 antibodiesADAGENE PTE LTD·Filed 2021·Application pending·0 cites
- 0947US2022089757A1Anti-cd137l antibodies and methods of using sameADAGENE PTE LTD·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →